Press release

19.09.2025 To the attention of interested persons First treatment recommended for rare immunoglobulin-related autoimmune disease download document …

Press release

05.09.2025 To the attention of interested persons PRAC starts safety review of levamisole, a medicine used to treat parasitic worm […]

Press release

05.09.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September […]

Press release

03.09.2025 To the attention of interested persons Warning about sharp rise in illegal medicines sold in the EU download document […]

Important notification

29.08.2025 To the attention of all interested parties According to the information received by the ANMDMR, counterfeit medical devices originating […]

Important notification

29.08.2025 To the attention of interested MAHs Working hours – REGISTRY As of the 1st of September 2025, the working […]

Press release

29.08.2025 To the attention of interested persons NAMMDR – Specifications on establishing the level of compensation of some medicinal products […]

Important notification

29.08.2025 To the attention of all interested parties According to the information obtained by the NAMMDR, counterfeit medical devices originating […]

Press release

26.08.2025 To the attention of interested persons Information regarding the misuse of the name of the National Agency for Medicines […]